Advertisement
Screener

10x Genomics, Inc. (TXG) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

2.8 / 5 stars · 68/120 Roast Me

10x Genomics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 24.64K shares, a 30.32% increase year-over-year.
  • 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 92.37K shares, a 66.68% decline year-over-year.
  • 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 137.35K shares, a 318.63% increase year-over-year.
  • 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-06-30 was 18.90K shares, a 60.76% decline year-over-year.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month
2026-06-3024.64K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
2026-03-3192.37K shares
10-Q · filed 2026-05-08
2025-09-30137.35K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
2025-06-3018.90K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
2025-03-31277.21K shares
10-Q · filed 2025-05-09
2024-09-3032.81K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29
2024-06-3048.17K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
2024-03-31160.38K shares
10-Q · filed 2024-04-30
2023-09-30363.07K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03
2023-06-30507.42K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04
2023-03-31581.11K shares
10-Q · filed 2023-05-04
2022-09-30347.63K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
2022-06-30326.29K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
2022-03-31652.18K shares
10-Q · filed 2022-05-05
2021-09-30699.70K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
2021-06-301.00M shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
2021-03-311.05M shares
10-Q · filed 2021-05-07
2020-09-30699.92K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
2020-06-301.95M shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12
2020-03-311.90M shares
10-Q · filed 2020-05-12